| Předmět: |
|
| Zdroj: |
Cancer Vaccine Week; 8/5/2024, p111-111, 1p |
| Abstrakt: |
A patent application has been filed for a method of increasing the antigenicity or immunogenicity of tumors in cancer patients. The method involves delivering lipid nanoparticles loaded with mRNA sequences encoding pathogen antigen proteins into the tumor. This approach aims to enhance the immune response against the tumor and potentially improve cancer therapy. The invention also suggests combining this method with immune checkpoint inhibitors for better therapeutic efficacy. The patent application references the use of mRNA-based COVID-19 vaccines, such as BNT162b2 (Comirnaty), as a potential strategy for cancer therapy. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
